nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ABCB1—Dactinomycin—muscle cancer	0.103	0.12	CbGbCtD
Enzalutamide—CYP3A5—Vincristine—muscle cancer	0.0978	0.113	CbGbCtD
Enzalutamide—CYP3A5—Etoposide—muscle cancer	0.0896	0.104	CbGbCtD
Enzalutamide—CYP2C8—Etoposide—muscle cancer	0.0862	0.0999	CbGbCtD
Enzalutamide—CYP2B6—Doxorubicin—muscle cancer	0.0776	0.0899	CbGbCtD
Enzalutamide—ALB—Methotrexate—muscle cancer	0.0737	0.0854	CbGbCtD
Enzalutamide—ABCB1—Vincristine—muscle cancer	0.0637	0.0738	CbGbCtD
Enzalutamide—ABCB1—Etoposide—muscle cancer	0.0583	0.0676	CbGbCtD
Enzalutamide—ABCB1—Doxorubicin—muscle cancer	0.0398	0.0461	CbGbCtD
Enzalutamide—ABCB1—Methotrexate—muscle cancer	0.0385	0.0447	CbGbCtD
Enzalutamide—CYP3A4—Vincristine—muscle cancer	0.0381	0.0442	CbGbCtD
Enzalutamide—CYP2D6—Doxorubicin—muscle cancer	0.0375	0.0434	CbGbCtD
Enzalutamide—CYP3A4—Etoposide—muscle cancer	0.035	0.0405	CbGbCtD
Enzalutamide—CYP3A4—Doxorubicin—muscle cancer	0.0238	0.0276	CbGbCtD
Enzalutamide—AR—scrotum—muscle cancer	0.0102	0.455	CbGeAlD
Enzalutamide—Lung infection—Methotrexate—muscle cancer	0.00703	0.0614	CcSEcCtD
Enzalutamide—Cognitive disorder—Methotrexate—muscle cancer	0.00267	0.0233	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Vincristine—muscle cancer	0.00241	0.021	CcSEcCtD
Enzalutamide—Sepsis—Dactinomycin—muscle cancer	0.00231	0.0202	CcSEcCtD
Enzalutamide—Fracture—Methotrexate—muscle cancer	0.00199	0.0173	CcSEcCtD
Enzalutamide—Multiple fractures—Methotrexate—muscle cancer	0.00199	0.0173	CcSEcCtD
Enzalutamide—Sepsis—Etoposide—muscle cancer	0.00167	0.0146	CcSEcCtD
Enzalutamide—Neutropenia—Dactinomycin—muscle cancer	0.00156	0.0136	CcSEcCtD
Enzalutamide—Muscular weakness—Vincristine—muscle cancer	0.00152	0.0133	CcSEcCtD
Enzalutamide—Pneumonia—Dactinomycin—muscle cancer	0.0015	0.0131	CcSEcCtD
Enzalutamide—Neutropenia—Vincristine—muscle cancer	0.0014	0.0122	CcSEcCtD
Enzalutamide—Laryngitis—Doxorubicin—muscle cancer	0.00139	0.0121	CcSEcCtD
Enzalutamide—Pneumonia—Vincristine—muscle cancer	0.00134	0.0117	CcSEcCtD
Enzalutamide—Pharyngitis—Dactinomycin—muscle cancer	0.00133	0.0116	CcSEcCtD
Enzalutamide—Musculoskeletal stiffness—Methotrexate—muscle cancer	0.00129	0.0112	CcSEcCtD
Enzalutamide—Hypoaesthesia—Vincristine—muscle cancer	0.00119	0.0104	CcSEcCtD
Enzalutamide—Urinary tract disorder—Vincristine—muscle cancer	0.00118	0.0103	CcSEcCtD
Enzalutamide—Connective tissue disorder—Vincristine—muscle cancer	0.00117	0.0102	CcSEcCtD
Enzalutamide—Urethral disorder—Vincristine—muscle cancer	0.00117	0.0102	CcSEcCtD
Enzalutamide—Neutropenia—Etoposide—muscle cancer	0.00113	0.00987	CcSEcCtD
Enzalutamide—Pneumonia—Etoposide—muscle cancer	0.00108	0.00946	CcSEcCtD
Enzalutamide—Angiopathy—Vincristine—muscle cancer	0.00108	0.00946	CcSEcCtD
Enzalutamide—Infestation NOS—Etoposide—muscle cancer	0.00108	0.00941	CcSEcCtD
Enzalutamide—Infestation—Etoposide—muscle cancer	0.00108	0.00941	CcSEcCtD
Enzalutamide—Mental disorder—Vincristine—muscle cancer	0.00105	0.00913	CcSEcCtD
Enzalutamide—Leukopenia—Dactinomycin—muscle cancer	0.00104	0.00909	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Doxorubicin—muscle cancer	0.00101	0.00883	CcSEcCtD
Enzalutamide—Back pain—Vincristine—muscle cancer	0.00101	0.00878	CcSEcCtD
Enzalutamide—Sepsis—Methotrexate—muscle cancer	0.001	0.00874	CcSEcCtD
Enzalutamide—Hypoaesthesia—Etoposide—muscle cancer	0.000963	0.0084	CcSEcCtD
Enzalutamide—Urinary tract disorder—Etoposide—muscle cancer	0.000956	0.00834	CcSEcCtD
Enzalutamide—Urethral disorder—Etoposide—muscle cancer	0.000949	0.00828	CcSEcCtD
Enzalutamide—Infection—Dactinomycin—muscle cancer	0.000944	0.00824	CcSEcCtD
Enzalutamide—Vertigo—Vincristine—muscle cancer	0.000934	0.00815	CcSEcCtD
Enzalutamide—Leukopenia—Vincristine—muscle cancer	0.000931	0.00812	CcSEcCtD
Enzalutamide—Thrombocytopenia—Dactinomycin—muscle cancer	0.00093	0.00812	CcSEcCtD
Enzalutamide—Convulsion—Vincristine—muscle cancer	0.000901	0.00786	CcSEcCtD
Enzalutamide—Hypertension—Vincristine—muscle cancer	0.000898	0.00784	CcSEcCtD
Enzalutamide—Angiopathy—Etoposide—muscle cancer	0.000878	0.00766	CcSEcCtD
Enzalutamide—Sepsis—Doxorubicin—muscle cancer	0.000867	0.00757	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000866	0.00755	CcSEcCtD
Enzalutamide—Infection—Vincristine—muscle cancer	0.000843	0.00736	CcSEcCtD
Enzalutamide—Nervous system disorder—Vincristine—muscle cancer	0.000832	0.00726	CcSEcCtD
Enzalutamide—Thrombocytopenia—Vincristine—muscle cancer	0.000831	0.00725	CcSEcCtD
Enzalutamide—Fatigue—Dactinomycin—muscle cancer	0.000819	0.00715	CcSEcCtD
Enzalutamide—Back pain—Etoposide—muscle cancer	0.000815	0.00711	CcSEcCtD
Enzalutamide—AR—smooth muscle tissue—muscle cancer	0.000776	0.0347	CbGeAlD
Enzalutamide—Hot flush—Doxorubicin—muscle cancer	0.000776	0.00677	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000773	0.00675	CcSEcCtD
Enzalutamide—Menopausal symptoms—Doxorubicin—muscle cancer	0.000769	0.00671	CcSEcCtD
Enzalutamide—Insomnia—Vincristine—muscle cancer	0.000768	0.0067	CcSEcCtD
Enzalutamide—Paraesthesia—Vincristine—muscle cancer	0.000762	0.00665	CcSEcCtD
Enzalutamide—Vertigo—Etoposide—muscle cancer	0.000757	0.0066	CcSEcCtD
Enzalutamide—Leukopenia—Etoposide—muscle cancer	0.000754	0.00658	CcSEcCtD
Enzalutamide—AR—renal system—muscle cancer	0.000747	0.0334	CbGeAlD
Enzalutamide—Gastrointestinal disorder—Vincristine—muscle cancer	0.000733	0.00639	CcSEcCtD
Enzalutamide—Fatigue—Vincristine—muscle cancer	0.000732	0.00639	CcSEcCtD
Enzalutamide—Convulsion—Etoposide—muscle cancer	0.00073	0.00637	CcSEcCtD
Enzalutamide—Hypertension—Etoposide—muscle cancer	0.000727	0.00635	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000712	0.00622	CcSEcCtD
Enzalutamide—Infection—Etoposide—muscle cancer	0.000683	0.00596	CcSEcCtD
Enzalutamide—Asthenia—Dactinomycin—muscle cancer	0.000682	0.00595	CcSEcCtD
Enzalutamide—Neutropenia—Methotrexate—muscle cancer	0.000677	0.00591	CcSEcCtD
Enzalutamide—Thrombocytopenia—Etoposide—muscle cancer	0.000673	0.00587	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000673	0.00587	CcSEcCtD
Enzalutamide—AR—cardiac atrium—muscle cancer	0.000669	0.0299	CbGeAlD
Enzalutamide—Skin disorder—Etoposide—muscle cancer	0.000668	0.00583	CcSEcCtD
Enzalutamide—Dry skin—Doxorubicin—muscle cancer	0.000665	0.0058	CcSEcCtD
Enzalutamide—Diarrhoea—Dactinomycin—muscle cancer	0.00065	0.00567	CcSEcCtD
Enzalutamide—Pneumonia—Methotrexate—muscle cancer	0.000649	0.00567	CcSEcCtD
Enzalutamide—Nasopharyngitis—Doxorubicin—muscle cancer	0.000649	0.00566	CcSEcCtD
Enzalutamide—Infestation NOS—Methotrexate—muscle cancer	0.000646	0.00563	CcSEcCtD
Enzalutamide—Infestation—Methotrexate—muscle cancer	0.000646	0.00563	CcSEcCtD
Enzalutamide—Muscular weakness—Doxorubicin—muscle cancer	0.00064	0.00558	CcSEcCtD
Enzalutamide—Paraesthesia—Etoposide—muscle cancer	0.000617	0.00539	CcSEcCtD
Enzalutamide—Haematuria—Methotrexate—muscle cancer	0.000616	0.00537	CcSEcCtD
Enzalutamide—Epistaxis—Methotrexate—muscle cancer	0.000609	0.00531	CcSEcCtD
Enzalutamide—Asthenia—Vincristine—muscle cancer	0.000609	0.00531	CcSEcCtD
Enzalutamide—CYP2C8—renal system—muscle cancer	0.000604	0.027	CbGeAlD
Enzalutamide—Bronchitis—Doxorubicin—muscle cancer	0.000603	0.00526	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Etoposide—muscle cancer	0.000594	0.00518	CcSEcCtD
Enzalutamide—Fatigue—Etoposide—muscle cancer	0.000593	0.00517	CcSEcCtD
Enzalutamide—Neutropenia—Doxorubicin—muscle cancer	0.000586	0.00512	CcSEcCtD
Enzalutamide—AR—tendon—muscle cancer	0.000583	0.0261	CbGeAlD
Enzalutamide—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000583	0.00509	CcSEcCtD
Enzalutamide—Diarrhoea—Vincristine—muscle cancer	0.000581	0.00507	CcSEcCtD
Enzalutamide—Pollakiuria—Doxorubicin—muscle cancer	0.000579	0.00506	CcSEcCtD
Enzalutamide—Pharyngitis—Methotrexate—muscle cancer	0.000575	0.00502	CcSEcCtD
Enzalutamide—Urinary tract disorder—Methotrexate—muscle cancer	0.000572	0.005	CcSEcCtD
Enzalutamide—Urethral disorder—Methotrexate—muscle cancer	0.000568	0.00496	CcSEcCtD
Enzalutamide—Pneumonia—Doxorubicin—muscle cancer	0.000562	0.00491	CcSEcCtD
Enzalutamide—Dizziness—Vincristine—muscle cancer	0.000561	0.0049	CcSEcCtD
Enzalutamide—Infestation NOS—Doxorubicin—muscle cancer	0.000559	0.00488	CcSEcCtD
Enzalutamide—Infestation—Doxorubicin—muscle cancer	0.000559	0.00488	CcSEcCtD
Enzalutamide—ALB—testis—muscle cancer	0.000556	0.0248	CbGeAlD
Enzalutamide—CYP3A5—renal system—muscle cancer	0.000545	0.0244	CbGeAlD
Enzalutamide—CYP2B6—renal system—muscle cancer	0.000542	0.0242	CbGeAlD
Enzalutamide—AR—vagina—muscle cancer	0.000541	0.0242	CbGeAlD
Enzalutamide—Haematuria—Doxorubicin—muscle cancer	0.000533	0.00465	CcSEcCtD
Enzalutamide—Headache—Vincristine—muscle cancer	0.000532	0.00464	CcSEcCtD
Enzalutamide—Epistaxis—Doxorubicin—muscle cancer	0.000527	0.0046	CcSEcCtD
Enzalutamide—Angiopathy—Methotrexate—muscle cancer	0.000526	0.00459	CcSEcCtD
Enzalutamide—Sinusitis—Doxorubicin—muscle cancer	0.000525	0.00458	CcSEcCtD
Enzalutamide—Mental disorder—Methotrexate—muscle cancer	0.000508	0.00443	CcSEcCtD
Enzalutamide—Rhinitis—Doxorubicin—muscle cancer	0.000503	0.00439	CcSEcCtD
Enzalutamide—CYP2C19—vagina—muscle cancer	0.000501	0.0224	CbGeAlD
Enzalutamide—AR—head—muscle cancer	0.0005	0.0223	CbGeAlD
Enzalutamide—Hypoaesthesia—Doxorubicin—muscle cancer	0.000499	0.00436	CcSEcCtD
Enzalutamide—Pharyngitis—Doxorubicin—muscle cancer	0.000498	0.00435	CcSEcCtD
Enzalutamide—Urinary tract disorder—Doxorubicin—muscle cancer	0.000496	0.00433	CcSEcCtD
Enzalutamide—Oedema peripheral—Doxorubicin—muscle cancer	0.000494	0.00431	CcSEcCtD
Enzalutamide—Asthenia—Etoposide—muscle cancer	0.000493	0.0043	CcSEcCtD
Enzalutamide—Connective tissue disorder—Doxorubicin—muscle cancer	0.000493	0.0043	CcSEcCtD
Enzalutamide—Urethral disorder—Doxorubicin—muscle cancer	0.000492	0.00429	CcSEcCtD
Enzalutamide—Back pain—Methotrexate—muscle cancer	0.000488	0.00426	CcSEcCtD
Enzalutamide—Pruritus—Etoposide—muscle cancer	0.000486	0.00424	CcSEcCtD
Enzalutamide—AR—testis—muscle cancer	0.000483	0.0216	CbGeAlD
Enzalutamide—Diarrhoea—Etoposide—muscle cancer	0.00047	0.00411	CcSEcCtD
Enzalutamide—Angiopathy—Doxorubicin—muscle cancer	0.000455	0.00397	CcSEcCtD
Enzalutamide—Dizziness—Etoposide—muscle cancer	0.000455	0.00397	CcSEcCtD
Enzalutamide—Vertigo—Methotrexate—muscle cancer	0.000453	0.00396	CcSEcCtD
Enzalutamide—Leukopenia—Methotrexate—muscle cancer	0.000452	0.00394	CcSEcCtD
Enzalutamide—Mental disorder—Doxorubicin—muscle cancer	0.00044	0.00384	CcSEcCtD
Enzalutamide—CYP2C8—vagina—muscle cancer	0.000438	0.0196	CbGeAlD
Enzalutamide—Convulsion—Methotrexate—muscle cancer	0.000437	0.00382	CcSEcCtD
Enzalutamide—Headache—Etoposide—muscle cancer	0.000431	0.00376	CcSEcCtD
Enzalutamide—Arthralgia—Methotrexate—muscle cancer	0.00043	0.00375	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000427	0.00372	CcSEcCtD
Enzalutamide—Back pain—Doxorubicin—muscle cancer	0.000423	0.00369	CcSEcCtD
Enzalutamide—CYP3A4—renal system—muscle cancer	0.000409	0.0183	CbGeAlD
Enzalutamide—Infection—Methotrexate—muscle cancer	0.000409	0.00357	CcSEcCtD
Enzalutamide—Nervous system disorder—Methotrexate—muscle cancer	0.000404	0.00352	CcSEcCtD
Enzalutamide—Thrombocytopenia—Methotrexate—muscle cancer	0.000403	0.00352	CcSEcCtD
Enzalutamide—CYP2D6—renal system—muscle cancer	0.000403	0.018	CbGeAlD
Enzalutamide—Skin disorder—Methotrexate—muscle cancer	0.0004	0.00349	CcSEcCtD
Enzalutamide—CYP3A5—vagina—muscle cancer	0.000395	0.0177	CbGeAlD
Enzalutamide—CYP2B6—vagina—muscle cancer	0.000393	0.0175	CbGeAlD
Enzalutamide—Vertigo—Doxorubicin—muscle cancer	0.000393	0.00343	CcSEcCtD
Enzalutamide—Leukopenia—Doxorubicin—muscle cancer	0.000391	0.00341	CcSEcCtD
Enzalutamide—CYP2C8—testis—muscle cancer	0.000391	0.0175	CbGeAlD
Enzalutamide—ABCB1—embryo—muscle cancer	0.000383	0.0171	CbGeAlD
Enzalutamide—Convulsion—Doxorubicin—muscle cancer	0.000379	0.0033	CcSEcCtD
Enzalutamide—Hypertension—Doxorubicin—muscle cancer	0.000377	0.00329	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000375	0.00327	CcSEcCtD
Enzalutamide—Insomnia—Methotrexate—muscle cancer	0.000372	0.00325	CcSEcCtD
Enzalutamide—Arthralgia—Doxorubicin—muscle cancer	0.000372	0.00325	CcSEcCtD
Enzalutamide—Anxiety—Doxorubicin—muscle cancer	0.000371	0.00323	CcSEcCtD
Enzalutamide—Paraesthesia—Methotrexate—muscle cancer	0.00037	0.00323	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000369	0.00322	CcSEcCtD
Enzalutamide—CYP2B6—head—muscle cancer	0.000363	0.0162	CbGeAlD
Enzalutamide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000356	0.0031	CcSEcCtD
Enzalutamide—Fatigue—Methotrexate—muscle cancer	0.000355	0.0031	CcSEcCtD
Enzalutamide—Infection—Doxorubicin—muscle cancer	0.000354	0.00309	CcSEcCtD
Enzalutamide—CYP2B6—testis—muscle cancer	0.00035	0.0157	CbGeAlD
Enzalutamide—Nervous system disorder—Doxorubicin—muscle cancer	0.00035	0.00305	CcSEcCtD
Enzalutamide—Thrombocytopenia—Doxorubicin—muscle cancer	0.000349	0.00305	CcSEcCtD
Enzalutamide—Skin disorder—Doxorubicin—muscle cancer	0.000346	0.00302	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000325	0.00284	CcSEcCtD
Enzalutamide—Insomnia—Doxorubicin—muscle cancer	0.000323	0.00281	CcSEcCtD
Enzalutamide—Paraesthesia—Doxorubicin—muscle cancer	0.00032	0.00279	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000308	0.00269	CcSEcCtD
Enzalutamide—Fatigue—Doxorubicin—muscle cancer	0.000307	0.00268	CcSEcCtD
Enzalutamide—Asthenia—Methotrexate—muscle cancer	0.000295	0.00258	CcSEcCtD
Enzalutamide—Pruritus—Methotrexate—muscle cancer	0.000291	0.00254	CcSEcCtD
Enzalutamide—ABCB1—renal system—muscle cancer	0.00029	0.0129	CbGeAlD
Enzalutamide—Diarrhoea—Methotrexate—muscle cancer	0.000282	0.00246	CcSEcCtD
Enzalutamide—Dizziness—Methotrexate—muscle cancer	0.000272	0.00238	CcSEcCtD
Enzalutamide—CYP2D6—head—muscle cancer	0.000269	0.012	CbGeAlD
Enzalutamide—CYP2D6—testis—muscle cancer	0.00026	0.0116	CbGeAlD
Enzalutamide—Headache—Methotrexate—muscle cancer	0.000258	0.00225	CcSEcCtD
Enzalutamide—Asthenia—Doxorubicin—muscle cancer	0.000256	0.00223	CcSEcCtD
Enzalutamide—Pruritus—Doxorubicin—muscle cancer	0.000252	0.0022	CcSEcCtD
Enzalutamide—Diarrhoea—Doxorubicin—muscle cancer	0.000244	0.00213	CcSEcCtD
Enzalutamide—Dizziness—Doxorubicin—muscle cancer	0.000236	0.00206	CcSEcCtD
Enzalutamide—Headache—Doxorubicin—muscle cancer	0.000223	0.00195	CcSEcCtD
Enzalutamide—ABCB1—bone marrow—muscle cancer	0.000219	0.00979	CbGeAlD
Enzalutamide—ABCB1—vagina—muscle cancer	0.00021	0.00938	CbGeAlD
Enzalutamide—ABCB1—head—muscle cancer	0.000194	0.00866	CbGeAlD
Enzalutamide—ABCB1—testis—muscle cancer	0.000187	0.00837	CbGeAlD
